Altamira Therapeutics Ltd. Increase Decrease In Cash And Cash Equivalents
Altamira Therapeutics Ltd. (CYTOF) reported Increase Decrease In Cash And Cash Equivalents of -$1.02 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2025-08-29
CHF
| Period end | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|
| 2023-12-31 | 555.42K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | -16.23K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | -993.07K CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | -575.39K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | -10.56M CHF 20-F/A · filed 2024-04-22 | |
| 2021-06-30 | -3.06M CHF 6-K/A · filed 2023-08-21 | |
| 2020-12-31 | 9.80M CHF 20-F · filed 2023-05-16 | |
| 2020-06-30 | -1.35M CHF 6-K · filed 2021-09-08 | |
| 2019-12-31 | -4.02M CHF 20-F · filed 2022-04-12 | |
| 2019-06-30 | 362.91K CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | -9.32M CHF 20-F · filed 2021-03-31 | |
| 2018-06-30 | -10.40M CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | -16.15M CHF 20-F · filed 2020-04-16 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|
| 2025-06-30 | -$1.02M 6-K · filed 2025-08-29 | |
| 2024-12-31 | $276.28K 20-F · filed 2025-04-30 | |
| 2024-06-30 | -$688.44K 6-K · filed 2025-08-29 | |
| 2023-12-31 | $618.16K 20-F · filed 2025-04-30 | |
| 2023-06-30 | -$17.79K 6-K · filed 2024-09-24 | |
| 2022-12-31 | -$1.04M 20-F · filed 2025-04-30 |